Patent · US Active

Spliceostatin analogs and methods for their preparation

US9169264B2 · kind B2 · utility

3Cited by

10References

39Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Chakrapani Subramanyam · South Glastonbury, US
Frank Koehn · Fort Pierce, US
Kenneth John Dirico · Gales Ferry, US
Alessandra S. Eustaquio · Old Saybrook, US
Michael Eric Green · Boston, US
Haiyin He · Hackettstown, US
Min He · Dongguan, CN
Christopher John O'Donnell · Mystic, US
Sujiet Puthenveetil · Attleboro, US
Anokha Ratnayake · Mystic, US
Jesse A. Teske · Westerly, US
Hui Yu Yang · Newton, US

Key dates

Filing date	Oct 31, 2013
Grant date	Oct 27, 2015
Priority date	—
Expiry date	Oct 31, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D493/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to novel cytotoxic spliceostatin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.